person · Reporting owner
PODUSKA JOHN WILLIAM SR
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lifeward Ltd.LFWD · Entity 7620 | Director | August 01, 2025 | August 07, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lifeward Ltd.
Report date August 01, 2025 · Filed August 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value NIS 1.75 per shareSEC Table I · non-derivative | IndirectESOP | 55,953 |
Reported balance
After 2025-08-01 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-08-01 · Grant · Acquired 35,920 · Balance 55,953 F1: Represents 35,920 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 1, 2025 (the "Grant Date") under the Lifeward Ltd. 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date. F2: The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-7 reverse share split, which became effective on March 15, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 35,920 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 1, 2025 (the "Grant Date") under the Lifeward Ltd. 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date.
F2: The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-7 reverse share split, which became effective on March 15, 2024.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
EXA CORP
Report date November 17, 2017 · Filed November 17, 2017
Section 16 reporting ended · disclosed 2017-11-17. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-11-17 transaction · row 1
1 source rowRow 1 · 2017-11-17 · Disposition to issuer · Disposed 66,574 · Balance 0 F1: Disposed of upon the effectiveness of the merger of 3DS Acquisition 3 Corp., Inc. ("3DS"), a wholly owned subsidiary of Dassault Systemes Simulia Corp. ("Dassault"), with and into the Issuer on November 17, 2017 pursuant to a merger agreement dated September 27, 2017 among Dassault, 3DS and the Issuer (the "Merger"). |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2017-11-17 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2017-11-17 · Disposition to issuer · Disposed 15,300 · Balance 0 F1: Disposed of upon the effectiveness of the merger of 3DS Acquisition 3 Corp., Inc. ("3DS"), a wholly owned subsidiary of Dassault Systemes Simulia Corp. ("Dassault"), with and into the Issuer on November 17, 2017 pursuant to a merger agreement dated September 27, 2017 among Dassault, 3DS and the Issuer (the "Merger"). F2: Represents shares purchased for a trust account over which the reporting person exercises investment control. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2017-11-17 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2017-11-17 · Disposition to issuer · Disposed 50,192 · Balance 0 F1: Disposed of upon the effectiveness of the merger of 3DS Acquisition 3 Corp., Inc. ("3DS"), a wholly owned subsidiary of Dassault Systemes Simulia Corp. ("Dassault"), with and into the Issuer on November 17, 2017 pursuant to a merger agreement dated September 27, 2017 among Dassault, 3DS and the Issuer (the "Merger"). F3: Shares held by Poduska Family Limited Partnership II. Belmont Management Corporation of which the reporting person's five adult children own all the issued and outstanding shares, is the general partner of Poduska Family Limited Partnership II. The reporting person, under an agreement between Belmont Management Corporation and Eagle's Nest Scientific, Inc., which is wholly owned by the reporting person and of which the reporting person is the president, treasurer and sole director, exercises sole voting and investment power over the shares held by Poduska Family Limited Partnership II. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-11-17 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-11-17 · Disposition to issuer · Disposed 5,353 · Balance 0 F4: Each restricted stock unit represented a contingent right to receive one share of the Issuer's common stock. F5: Upon the effectiveness of the Merger, the restricted stock units became fully vested and were canceled in exchange for a cash payment of $129,810.25 (representing a price of $24.25 per restricted stock unit). |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.32 | Direct | 0 |
Reported balance
After 2017-11-17 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-11-17 · Disposition to issuer · Disposed 2,582 · Balance 0 F6: Upon the effectiveness of the Merger, the option was canceled in exchange for a cash payment of $23,057.26 (representing the difference between the merger consideration of $24.25 per share and the per share exercise price of the option multiplied by the number of shares subject to the option). |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.38 | Direct | 0 |
Reported balance
After 2017-11-17 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-11-17 · Disposition to issuer · Disposed 38,461 · Balance 0 F7: Upon the effectiveness of the Merger, the option was canceled in exchange for a cash payment of $494,993.07 (representing the difference between the merger consideration of $24.25 per share and the per share exercise price of the option multiplied by the number of shares subject to the option). |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of upon the effectiveness of the merger of 3DS Acquisition 3 Corp., Inc. ("3DS"), a wholly owned subsidiary of Dassault Systemes Simulia Corp. ("Dassault"), with and into the Issuer on November 17, 2017 pursuant to a merger agreement dated September 27, 2017 among Dassault, 3DS and the Issuer (the "Merger").
F2: Represents shares purchased for a trust account over which the reporting person exercises investment control. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F3: Shares held by Poduska Family Limited Partnership II. Belmont Management Corporation of which the reporting person's five adult children own all the issued and outstanding shares, is the general partner of Poduska Family Limited Partnership II. The reporting person, under an agreement between Belmont Management Corporation and Eagle's Nest Scientific, Inc., which is wholly owned by the reporting person and of which the reporting person is the president, treasurer and sole director, exercises sole voting and investment power over the shares held by Poduska Family Limited Partnership II.
F4: Each restricted stock unit represented a contingent right to receive one share of the Issuer's common stock.
F5: Upon the effectiveness of the Merger, the restricted stock units became fully vested and were canceled in exchange for a cash payment of $129,810.25 (representing a price of $24.25 per restricted stock unit).
F6: Upon the effectiveness of the Merger, the option was canceled in exchange for a cash payment of $23,057.26 (representing the difference between the merger consideration of $24.25 per share and the per share exercise price of the option multiplied by the number of shares subject to the option).
F7: Upon the effectiveness of the Merger, the option was canceled in exchange for a cash payment of $494,993.07 (representing the difference between the merger consideration of $24.25 per share and the per share exercise price of the option multiplied by the number of shares subject to the option).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2025 Filed Aug 7, 2025 18:08 UTC | Lifeward Ltd. LFWD · Entity 7620 | GrantOrdinary Shares, par value NIS 1.75 per share | 35,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-013869 · form4.xml · nonDerivative · entry 1 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · ESOP Disclosed balance after: 55,953 F1 · shares: Represents 35,920 ordinary shares, par value NIS 1.75 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 1, 2025 (the "Grant Date") under the Lifeward Ltd. 2025 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date. F2 · balance_after: The reported number of shares has been adjusted to reflect the impact of the Issuer's 1-for-7 reverse share split, which became effective on March 15, 2024. Read SEC document |
| September 13, 2023 Filed Sep 19, 2023 16:37 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 59,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-018264 · form4.xml · nonDerivative · entry 1 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · ESOP Disclosed balance after: 140,240 F1 · shares: Represents 59,595 ordinary shares, par value NIS 0.25 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on September 13, 2023 (the "Grant Date") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the Grant Date. Read SEC document |
| August 02, 2022 Filed Aug 3, 2022 16:05 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-017164 · form4.xml · nonDerivative · entry 1 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 80,645 F1 · shares: Represents 50,000 ordinary shares, par value NIS 0.25 per share, issuable upon the vesting of restricted stock units ("RSUs") granted on August 2, 2022 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest ratably in four equal quarterly installments starting three months following the date of grant. Read SEC document |
| May 21, 2021 Filed May 24, 2021 17:15 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001850 · zk2126085.xml · nonDerivative · entry 1 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 37,590 F1 · shares: Represents 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on May 21, 2021 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. Read SEC document |
| May 21, 2021 Filed May 27, 2021 17:12 UTC Amendment | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 13,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-21-001943 · zk2126121.xml · nonDerivative · entry 1 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 30,645 F1 · shares: The Reporting Person is amending the Form 4 filed on May 24, 2021, which, due to an administrative error, inadvertently reported the grant on May 21, 2021 of 20,833 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The Reporting Person was actually granted 13,888 Ordinary Shares, issuable upon the vesting of RSUs. The RSUs vest in four equal quarterly instalments starting three months following the date of grant. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 17:11 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.25 per share | 10,948 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-20-001993 · zk2024593.xml · nonDerivative · entry 1 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 16,757 F1 · shares: Represents 9,036 ordinary shares, par value NIS 0.25 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on July 2, 2020 under the ReWalk Robotics Ltd. Amended and Restated 2014 Incentive Compensation Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant. F2 · balance_after: Reflects our one-for-twenty-five reverse share split that became effective on April 1, 2019. Read SEC document |
| March 27, 2019 Filed Mar 28, 2019 07:19 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 116,496 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-19-005037 · doc4.xml · nonDerivative · entry 1 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 145,245 F1 · shares: Represents 116,496 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on March 27, 2019 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant. F2 · balance_after: Pursuant to the terms of the ReWalk 2014 Incentive Compensation Plan permitting the board of directors of ReWalk Robotics Ltd. (the ?Company?) to adjust the number of shares underlying equity awards in connection with stock splits, reverse stock splits or similar corporate events, the number of Ordinary Shares underlying the RSUs is subject to adjustment in connection with the Company?s planned reverse stock split, which the Company intends to effect shortly following its receipt of shareholder approval for such split on March 27, 2019. Read SEC document |
| April 30, 2018 Filed May 2, 2018 16:00 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 22,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001607962-18-000017 · wf-form4_152529120250370.xml · nonDerivative · entry 1 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 28,749 F1 · shares: Represents 22,727 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs") granted on April 30, 2018 under the ReWalk 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant. Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 16:39 UTC | EXA CORP EXA · Entity 169415 | Disposition to issuerStock Option (Right to Buy) · Derivative | 38,461 | $12.87 Strike: $11.38 | $494,993.07 |
DisclosureSEC source: 0001209191-17-061515 · doc4.xml · derivative · entry 6 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 38,461 shares Expires not disclosed F7 · price: Upon the effectiveness of the Merger, the option was canceled in exchange for a cash payment of $494,993.07 (representing the difference between the merger consideration of $24.25 per share and the per share exercise price of the option multiplied by the number of shares subject to the option). F7 · derivative.exercise_date: Upon the effectiveness of the Merger, the option was canceled in exchange for a cash payment of $494,993.07 (representing the difference between the merger consideration of $24.25 per share and the per share exercise price of the option multiplied by the number of shares subject to the option). F7 · derivative.expiration_date: Upon the effectiveness of the Merger, the option was canceled in exchange for a cash payment of $494,993.07 (representing the difference between the merger consideration of $24.25 per share and the per share exercise price of the option multiplied by the number of shares subject to the option). Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 16:39 UTC | EXA CORP EXA · Entity 169415 | Disposition to issuerStock Option (Right to Buy) · Derivative | 2,582 | $8.93 Strike: $15.32 | $23,057.26 |
DisclosureSEC source: 0001209191-17-061515 · doc4.xml · derivative · entry 5 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,582 shares Expires not disclosed F6 · price: Upon the effectiveness of the Merger, the option was canceled in exchange for a cash payment of $23,057.26 (representing the difference between the merger consideration of $24.25 per share and the per share exercise price of the option multiplied by the number of shares subject to the option). F6 · derivative.exercise_date: Upon the effectiveness of the Merger, the option was canceled in exchange for a cash payment of $23,057.26 (representing the difference between the merger consideration of $24.25 per share and the per share exercise price of the option multiplied by the number of shares subject to the option). F6 · derivative.expiration_date: Upon the effectiveness of the Merger, the option was canceled in exchange for a cash payment of $23,057.26 (representing the difference between the merger consideration of $24.25 per share and the per share exercise price of the option multiplied by the number of shares subject to the option). Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 16:39 UTC | EXA CORP EXA · Entity 169415 | Disposition to issuerRestricted Stock Units · Derivative | 5,353 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-061515 · doc4.xml · derivative · entry 4 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,353 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represented a contingent right to receive one share of the Issuer's common stock. F5 · price: Upon the effectiveness of the Merger, the restricted stock units became fully vested and were canceled in exchange for a cash payment of $129,810.25 (representing a price of $24.25 per restricted stock unit). F5 · derivative.exercise_date: Upon the effectiveness of the Merger, the restricted stock units became fully vested and were canceled in exchange for a cash payment of $129,810.25 (representing a price of $24.25 per restricted stock unit). F5 · derivative.expiration_date: Upon the effectiveness of the Merger, the restricted stock units became fully vested and were canceled in exchange for a cash payment of $129,810.25 (representing a price of $24.25 per restricted stock unit). Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 16:39 UTC | EXA CORP EXA · Entity 169415 | Disposition to issuerCommon Stock | 50,192 | $24.25 | $1,217,156.00 |
DisclosureSEC source: 0001209191-17-061515 · doc4.xml · nonDerivative · entry 3 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · price: Disposed of upon the effectiveness of the merger of 3DS Acquisition 3 Corp., Inc. ("3DS"), a wholly owned subsidiary of Dassault Systemes Simulia Corp. ("Dassault"), with and into the Issuer on November 17, 2017 pursuant to a merger agreement dated September 27, 2017 among Dassault, 3DS and the Issuer (the "Merger"). F3 · ownership.nature: Shares held by Poduska Family Limited Partnership II. Belmont Management Corporation of which the reporting person's five adult children own all the issued and outstanding shares, is the general partner of Poduska Family Limited Partnership II. The reporting person, under an agreement between Belmont Management Corporation and Eagle's Nest Scientific, Inc., which is wholly owned by the reporting person and of which the reporting person is the president, treasurer and sole director, exercises sole voting and investment power over the shares held by Poduska Family Limited Partnership II. Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 16:39 UTC | EXA CORP EXA · Entity 169415 | Disposition to issuerCommon Stock | 15,300 | $24.25 | $371,025.00 |
DisclosureSEC source: 0001209191-17-061515 · doc4.xml · nonDerivative · entry 2 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · price: Disposed of upon the effectiveness of the merger of 3DS Acquisition 3 Corp., Inc. ("3DS"), a wholly owned subsidiary of Dassault Systemes Simulia Corp. ("Dassault"), with and into the Issuer on November 17, 2017 pursuant to a merger agreement dated September 27, 2017 among Dassault, 3DS and the Issuer (the "Merger"). F2 · ownership.nature: Represents shares purchased for a trust account over which the reporting person exercises investment control. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| November 17, 2017 Filed Nov 17, 2017 16:39 UTC | EXA CORP EXA · Entity 169415 | Disposition to issuerCommon Stock | 66,574 | $24.25 | $1,614,419.50 |
DisclosureSEC source: 0001209191-17-061515 · doc4.xml · nonDerivative · entry 1 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Disposed of upon the effectiveness of the merger of 3DS Acquisition 3 Corp., Inc. ("3DS"), a wholly owned subsidiary of Dassault Systemes Simulia Corp. ("Dassault"), with and into the Issuer on November 17, 2017 pursuant to a merger agreement dated September 27, 2017 among Dassault, 3DS and the Issuer (the "Merger"). Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 08:51 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOption (Right to buy) · Derivative | 4,176 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001628280-17-006799 · wf-form4_149874066278058.xml · derivative · entry 1 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,176 Underlying: Ordinary Shares, par value NIS 0.01 per share · 4,176 shares Expires 2027-06-27 F1 · derivative.exercise_date: Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on June 27, 2017. The options become vested and exercisable in four equal quarterly installments starting three months following the date of grant. Read SEC document |
| June 15, 2017 Filed Jun 19, 2017 16:33 UTC | EXA CORP EXA · Entity 169415 | GrantRestricted Stock Units · Derivative | 5,353 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040837 · doc4.xml · derivative · entry 1 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,353 Underlying: Common Stock · 5,353 shares Expires not disclosed F1 · derivative.exercise_price: Upon vesting, each restricted stock unit converts into one share of Exa common stock. F2 · derivative.exercise_date: The restricted stock units shall become fully vested on June 15, 2018 or at the next annual meeting of the Exa stockholders, whichever is earlier. F2 · derivative.expiration_date: The restricted stock units shall become fully vested on June 15, 2018 or at the next annual meeting of the Exa stockholders, whichever is earlier. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 17:56 UTC | EXA CORP EXA · Entity 169415 | Exercise / conversionRestricted Stock Units · Derivative | 6,097 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040629 · doc4.xml · derivative · entry 4 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,097 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon vesting, each restricted stock unit converts into one share of Exa common stock. F4 · derivative.exercise_date: On June 14, 2016, the reporting person was granted 6,097 restricted stock units that vested in full on June 14, 2017. F4 · derivative.expiration_date: On June 14, 2016, the reporting person was granted 6,097 restricted stock units that vested in full on June 14, 2017. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 17:56 UTC | EXA CORP EXA · Entity 169415 | Exercise / conversionCommon Stock | 6,097 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-040629 · doc4.xml · nonDerivative · entry 1 PODUSKA JOHN WILLIAM SR · CIK 0001190078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon vesting, each restricted stock unit converts into one share of Exa common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.